1,607 results on '"Le Roux, Carel W."'
Search Results
2. Metabolic/Bariatric Surgery is Safe and Effective in People with Obesity, Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
3. Laxative Properties of Microencapsulated Oleic Acid Delivered to the Distal Small Intestine in Patients with Constipation after Bariatric Surgery or Treatment with Glucagon-Like- Peptide 1 Analogues
4. Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
5. Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors—protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial)
6. Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program
7. The Effects of Sleeve Gastrectomy on the Appetitive Domain of Taste Using the Progressive Ratio Task
8. The emergence of obesity in type 1 diabetes
9. Perceived Benefits of Bariatric Surgery: Patient Perspectives
10. Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
11. Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study
12. Harnessing the melanocortin system in the control of food intake and glucose homeostasis
13. Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial
14. Effect of Bariatric Surgery on Serum Amyloid A Protein: a Systematic Review and Meta-analysis
15. Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
16. Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review
17. Weight loss to disrupt type 2 diabetes
18. Patient perspectives on personalised medicine for obesity: An IMI2 SOPHIA Study
19. Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial
20. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
21. Unintentional Weight Loss and Malnutrition After Esophageal Cancer and Treatment
22. Glycemic Control and Reduction of Cardiorenal Risk Following Bariatric Surgery
23. Concept of Metabolic Surgery
24. Mechanisms of Action of Different Bariatric Surgical Procedures
25. Chapters on Metabolic Syndrome Control and the Influence of Hormonal Changes Post-duodenal Switch (DS)
26. Survodutide for the Treatment of Obesity: Rationale and Design of the SYNCHRONIZE Cardiovascular Outcomes Trial
27. Food preferences after bariatric surgery: a review update
28. Mechanisms of Action of Bariatric Surgery on Body Weight Regulation
29. Pharmacotherapy before and after bariatric surgery
30. Development and validation of an interpretable machine learning-based calculator for predicting 5-year weight trajectories after bariatric surgery: a multinational retrospective cohort SOPHIA study
31. A review of the evidence on cardiovascular outcomes from obesity treatment
32. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
33. Achieving consensus on the language of obesity: a modified Delphi study
34. Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
35. Unintentional Weight Loss and Malnutrition After Esophageal Cancer and Treatment
36. Obesity Is a Disease
37. Correction: Is Metabolic Surgery Having an Identity Crisis?
38. Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trial
39. The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy
40. The Relationship Between Percentage Weight Loss and World Health Organization-Five Wellbeing Index (WHO-5) in Patients Having Bariatric Surgery
41. Ciliary neurotrophic factor is increased in the plasma of patients with obesity and its levels correlate with diabetes and inflammation indices
42. Upper gut heat shock proteins HSP70 and GRP78 promote insulin resistance, hyperglycemia, and non-alcoholic steatohepatitis
43. Understanding the risk of developing weight-related complications associated with different body mass index categories: a systematic review
44. Remission of diabetes and cardiometabolic risk in patients after 5 years of bariatric surgery: A case-control study
45. Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes.
46. Anti‐obesity treatment preferences of healthcare providers and people living with obesity: A survey‐based study.
47. Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes.
48. Other Potential Benefits of the Sleeve: Effects on Body Fat Setpoint
49. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation
50. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.